Search results
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoImage source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q1 2024 Earnings Call Apr 25, 2024,...
Gilead posts quarterly loss, revenue rises 5%
Reuters· 9 hours agoGilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay...
Gilead stock gains on revenue beat, despite a quarterly loss By Investing.com
Investing.com· 8 hours agoGilead Sciences, Inc. (NASDAQ:GILD) has reported a revenue increase in its first quarter of 2024,...
Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus
Seeking Alpha· 6 hours agoGilead Sciences reports Q1 2024 financial results with a diluted EPS loss due to charges from...
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
GuruFocus.com via Yahoo Finance· 8 hours agoEffective Tax Rate: Reduced significantly to 7.0% in Q1 2024 from 24.3% in Q1 2023, influenced by...
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
Investor's Business Daily· 9 hours agoGilead Sciences (GILD) beat Wall Street's first-quarter sales forecasts Thursday on the back of its...
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 8 hours agoGilead (GILD) delivered earnings and revenue surprises of 11.41% and 5.59%, respectively, for the...
Gilead Sciences Posts Higher 1Q Sales, Swings to Loss on Charges
Morningstar· 9 hours agoBy Paul Ziobro Gilead Sciences posted higher first-quarter sales, but swung to a steep loss due to charges related to recent acquisitions, prompting the ...
Gilead's quarterly loss is narrower than expected
Morningstar· 9 hours agoGilead Sciences Inc.'s stock rose 0.8% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected ...
Gilead: Q1 Earnings Snapshot
Houston Chronicle· 9 hours agoFOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported a loss of $4.17 billion in its first quarter. The Foster City, California-based ...
